NEW YORK (GenomeWeb News) – Millipore said today that it will work with Agilent Technologies to develop chromatin immunoprecipitation kits for the epigenetics research market.
 
The collaboration will involve teaming Millipore’s knowledge in ChIP kits, reagents, and antibodies with Agilent’s microarray and data analysis solutions, the Billerica, Mass.-based Millipore stated.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Direct-to-consumer genetic testing companies have offered to test families separated at the southern US border, but that raises ethical issues.

CNBC reports that confirming a positive result from 23andMe's BRCA health report can be expensive.

The New York Times reports on a project to develop a tree DNA database to uncover illegal logging.

In PLOS this week: links between gut microbiome and colorectal cancer mutations, targeted sequencing uncovers genetic susceptibilities to epilepsy in Koreans, and more.